Guadagnuolo V, Papayannidis C, Iacobucci I, et al. SIRPB1: biomarker of response to 5-azacitidine treatment in MDS and AML patients. EHA 2017, abstract E1201.
Chemotherapievrije behandeling met dasatinib plus blinatumomab bij Ph+ ALL
jan 2021 | Leukemie